Literature DB >> 25557073

Cytologic diagnostic approach to poorly differentiated thyroid carcinoma: a single-institution study.

Shubhada V Kane1, Tanvi Paliwal Sharma.   

Abstract

BACKGROUND: Fine-needle aspiration cytology (FNAC) is a well-established technique for the preoperative evaluation of thyroid nodules because it is minimally invasive, cost-effective, quick, efficient, and safe. Various articles have discussed differences in the cytomorphology of different types of thyroid cancer. However, review articles on the cytologic diagnosis of poorly differentiated thyroid carcinoma (PDTC) are scarce as PDTC are rare tumors. Although the histologic diagnostic criteria are well standardized, the cytologic diagnostic criteria are not yet standardized. This prompted us to study the cytomorphological features of PDTC and assess features of distinction from differentiated thyroid carcinoma (DTC) and medullary thyroid carcinoma (MTC).
METHODS: This was a retrospective study of thyroid FNAC smears from 44 PDTC cases retrieved from the database of a single tertiary cancer institute (2009-2013). Papanicolaou and Giemsa smears were evaluated for 21 cytomorphologic features. Immunocytochemistry was available for 6 cases only.
RESULTS: The frequencies of cytomorphologic features in the 44 cases were as follows: hypercellularity, 84.1%; insular pattern, 79.5%; small cell size, 93.2%; high nuclear-cytoplasmic ratio, 93.2%; granular chromatin pattern, 95.45%; nuclear overlapping, 88.64%; mild pleomorphism, 86.36%; grooves/inclusions, 22.7%; binucleation/multinucleation, 9.1%; abrupt nucleomegaly, 34.1%; apoptosis, 45%; mitosis, 25%; necrosis, 34.1%; and colloid, 22.7%.
CONCLUSION: A high index of suspicion is necessary for an upfront diagnosis of PDTC on FNAC. Although PDTC, DTC, and MTC have overlapping features, there are distinguishing features also. The cytologic diagnostic criteria for PDTC need to be standardized by collaborative efforts among tertiary cancer centers. A prompt diagnosis is the key feature for planning multimodality treatment.
© 2014 American Cancer Society.

Entities:  

Keywords:  cytologic diagnosis; immunocytochemistry; insular carcinoma; microfollicular pattern; upfront diagnosis

Mesh:

Year:  2014        PMID: 25557073     DOI: 10.1002/cncy.21500

Source DB:  PubMed          Journal:  Cancer Cytopathol        ISSN: 1934-662X            Impact factor:   5.284


  6 in total

Review 1.  Pitfalls in Thyroid Cytopathology.

Authors:  Esther Diana Rossi; Adebowale J Adeniran; William C Faquin
Journal:  Surg Pathol Clin       Date:  2019-12

2.  Treating Clinically Node-Negative Insular Thyroid Carcinoma without Prophylactic Central Compartment Neck Dissection Is Associated with Decreased Survival Regardless of T Staging and Administration of Radioactive Iodine Therapy: The First Evidence.

Authors:  Peng-Cheng Yu; Xiao Shi; Ben Ma; Cui-Wei Li; Li-Cheng Tan; Wei-Ping Hu; Yu Wang; Wen-Jun Wei; Yu-Long Wang; Qing-Hai Ji
Journal:  Int J Endocrinol       Date:  2019-10-16       Impact factor: 3.257

Review 3.  Poorly differentiated thyroid carcinoma : An underdiagnosed entity.

Authors:  M S Dettmer; A Schmitt; P Komminoth; A Perren
Journal:  Pathologe       Date:  2020-06       Impact factor: 1.011

4.  Contribution of cytologic examination to diagnosis of poorly differentiated thyroid carcinoma.

Authors:  Na Rae Kim; Jae Yeon Seok; Yoo Seung Chung; Joon Hyop Lee; Dong Hae Chung
Journal:  J Pathol Transl Med       Date:  2020-02-05

5.  Cytomorphological study of thyroid carcinoma.

Authors:  Iuliana Mohorea; Dana Terzea; Daniela Mihalache; Bogdan Socea; Dragoş Şerban; Mihai Ceausu
Journal:  Exp Ther Med       Date:  2021-12-06       Impact factor: 2.447

Review 6.  Challenges in Cytology Specimens With Hürthle Cells.

Authors:  Eleni Thodou; Sule Canberk; Fernando Schmitt
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-25       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.